Awiqli® (insulin icodec): Novo Nordisk India launches World’s First Once-Weekly Basal Insulin
- Jul 08, 2026
- 6
From daily injection to just once a week, Novo Nordisk sets a new standard of convenience in diabetes care* First and only once-weekly basal insulin — a global innovation in diabetes therapy1* Reduces injection burden significantly, from 7 injections per week to just 1; expected to ease injection barrier, especially in India where insulin is delayed by ~7-9 years* Backed by a robust clinical trial program, including Indian population, which showed superior HbA1c reduction, better time in...
